Across TCGA pan-cancer cohorts, BMP2KL RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated BMP2KL data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher BMP2KL RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BMP2KL expression acts as an unfavorable survival marker, although some lineages such as LAML and BRCA show a favorable association.
BLCA, CHOL, and UVM are the cancer types where BMP2KL RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.